Project Grant F32DA062455
Award Date
6/12/25
Completion Date
12/31/28
Dollars Obligated
$155K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
St. Louis, MO 63110, USA
Similar Awards
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders grant program (CFDA 93.853), provides $497,550.00 to The Washington University in St. Louis to conduct research on understanding how endogenous opioid systems regulate the analgesic (pain-relieving) properties of the locus coeruleus noradrenergic system. The research aims to elucidate the mechanisms by which...
This National Institutes of Health National Institute on Drug Abuse Project Grant award of $234,364.35 supports research from March 1, 2021 through August 31, 2022 at clinical practices of the University of Pennsylvania located in Pennsylvania. The research aims to characterize a nociception-active basolateral amygdala to anterior cingulate cortex circuit that contributes to affective-attention pain behaviors, and determine its overlap with endogenous mu opioid receptor systems. The grant also...
This $2,103,564 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to investigate the cellular mechanisms and therapeutic potential of the nuclear receptor NR4A1 in pain resolution. The grant will fund research to test whether NR4A1 in macrophages controls the resolution of inflammation and postoperative pain, whether NR4A1 agonists can promote pain resolution, and whether NR4A1...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $172,596 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The Washington University in St. Louis. The 5-year grant, effective August 12, 2024, supports the Promoting Excellence through Pain and Addiction Research Enhancement (PREPARE) T90/R90 postdoctoral training program. The program aims to recruit and train early career investigators to conduct clinical research on the...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $158,512 to the University of Pittsburgh to characterize the role of orexinergic neurons in the spinal cord and their impact on chronic pain transmission. The research aims to use physiological and behavioral approaches to investigate how orexinergic projections from the...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $173,799 to support a 2-year research project at the University of Pennsylvania focused on understanding the role of the brain's endogenous opioid system in pain and placebo analgesia. The project aims to investigate the signaling dynamics and function of enkephalinergic neural populations in the ventrolateral periaqueductal gray (VLPAG) and the...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), part of the Drug Use and Addiction Research Programs (CFDA 93.279), provides $2,068,842 to Trustees of Indiana University (Indianapolis) to conduct research on the role of prefrontal cortical dynorphin circuits in modulating pain states and associated maladaptive behaviors. The 3-year grant, awarded on September 20, 2024, aims to use ex-vivo electrophysiology and in-vivo calcium imaging...
This National Institute of Neurological Disorders and Stroke (NINDS) Project Grant award of $242,061.00 under the Drug Use and Addiction Research Programs (CFDA 93.279) supports the establishment of the Mass General Brigham Interdisciplinary Clinical Pain Research Training Program. This program will provide a 2-3 year training and research experience for a diverse pool of postdoctoral fellows, with the goal of expanding the cadre of early-career clinical pain researchers capable of launching...
This federal Project Grant award, with ID R21NS137066, was issued by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The award of $246,750 to The Trustees of Columbia University in the City of New York will fund research to investigate the role of the mesocortical glutamatergic pathway, which connects the ventral tegmental area to the prefrontal cortex, in the...
The federal Project Grant award R01NS136363, totaling $453,104.00, was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The grant supports research to explore the role of two distinct subtypes of spinal projection neurons, TACR1- and GPR83-expressing, in conveying pain signals to the brain and their potential as therapeutic targets for chronic...